Filing Details

Accession Number:
0001012975-13-000439
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-16 17:48:59
Reporting Period:
2013-09-12
Filing Date:
2013-09-16
Accepted Time:
2013-09-16 17:48:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100412 Array Biopharma Inc ARRY Pharmaceutical Preparations (2834) 841460811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1547100 Liam Ratcliffe C/O New Leaf Venture Partners
7 Times Square, Suite 3502
New York NY 10036
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-09-12 807,479 $6.10 1,991,421 No 4 S Indirect See footnote
Common Stock Disposition 2013-09-13 546,660 $6.01 1,444,761 No 4 S Indirect See footnote
Common Stock Disposition 2013-09-16 319,033 $6.14 1,125,728 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. Represents shares owned directly by New Leaf Ventures II, L.P., a limited partnership of which the sole general partner is New Leaf Venture Associates II, L.P. ("NLVA II"). Dr. Liam Ratcliffe ("Dr. Ratcliffe"), in his capacity as a limited partner of NLVA II, may be deemed to beneficially own the shares to which this Form 4 relates. Dr. Ratcliffe disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.